Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - midazolam, quantity: 15 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - intravenously (iv) as an agent for: . - conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid . - induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. .,intermittent iv administration or continuous infusion for: . - sedation in intensive care units, intermittent administration or continuous infusion.,intramuscularly (im) for: . - preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - cimetidine -

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - injection - see ingredients - each 2 ml solution contains cimetidine 200 mg

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

smith_kb -